争议事件
以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。
返回词条共 4 条
2020
罗马尼亚因Roche涉嫌妨碍癌症药物竞争而对其罚款
罚款或处罚
罗马尼亚反垄断机构因Roche采取妨碍两种癌症药物竞争的策略，对其罚款1,400万美元。报道提及的指控涉及向参与国家癌症药物项目及医院供货竞标的分销商定价。
来源摘录
ollowing a two-year investigation, Roche (FRHHBY) was fined $14 million by antitrust authorities in Romania for using different tactics to impede competition to a pair of its cancer medicines, the latest effort by European governments to crack down on anti-competitive practices.
In one instance, Roche allegedly monopolized the market for Rituxan and Herceptin by undercutting rival bidders in auctions that were held to supply a national program for cancer medicines as well as hospitals.
1976
1973
1940